Skip to main content

Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study.

Publication ,  Conference
Berg, SL; Blaney, SM; Bernstein, M; Kurtzberg, J; Devidas, M; Lampkin, T; Murgo, AJ; Harris, MB
Published in: BLOOD
November 16, 2003

Duke Scholars

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2003

Volume

102

Issue

11

Start / End Page

226A / 226A

Location

SAN DIEGO, CALIFORNIA

Publisher

AMER SOC HEMATOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Berg, S. L., Blaney, S. M., Bernstein, M., Kurtzberg, J., Devidas, M., Lampkin, T., … Harris, M. B. (2003). Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study. In BLOOD (Vol. 102, pp. 226A-226A). SAN DIEGO, CALIFORNIA: AMER SOC HEMATOLOGY.
Berg, S. L., S. M. Blaney, M. Bernstein, J. Kurtzberg, M. Devidas, T. Lampkin, A. J. Murgo, and M. B. Harris. “Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study.” In BLOOD, 102:226A-226A. AMER SOC HEMATOLOGY, 2003.
Berg SL, Blaney SM, Bernstein M, Kurtzberg J, Devidas M, Lampkin T, et al. Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study. In: BLOOD. AMER SOC HEMATOLOGY; 2003. p. 226A-226A.
Berg, S. L., et al. “Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study.BLOOD, vol. 102, no. 11, AMER SOC HEMATOLOGY, 2003, pp. 226A-226A.
Berg SL, Blaney SM, Bernstein M, Kurtzberg J, Devidas M, Lampkin T, Murgo AJ, Harris MB. Activity of compound 506U78 in patients with refractory T-cell malignancies: A POG/CCG intergroup phase 2 study. BLOOD. AMER SOC HEMATOLOGY; 2003. p. 226A-226A.

Published In

BLOOD

ISSN

0006-4971

Publication Date

November 16, 2003

Volume

102

Issue

11

Start / End Page

226A / 226A

Location

SAN DIEGO, CALIFORNIA

Publisher

AMER SOC HEMATOLOGY

Conference Name

45th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology